Active Ingredient: BESIFLOXACIN HYDROCHLORIDE
Proprietary Name: BESIVANCE
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: EQ 0.6% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N022308
Product Number: 001
Approval Date: May 28, 2009
Applicant Holder Full Name: BAUSCH AND LOMB INC
Marketing Status:
Prescription
Patent and Exclusivity Information
